Bill Text: CA SCR120 | 2015-2016 | Regular Session | Chaptered
Bill Title: Biotechnology Day.
Spectrum: Slight Partisan Bill (Democrat 11-5)
Status: (Passed) 2016-04-11 - Chaptered by Secretary of State. Res. Chapter 21, Statutes of 2016. [SCR120 Detail]
Download: California-2015-SCR120-Chaptered.html
BILL NUMBER: SCR 120 CHAPTERED BILL TEXT RESOLUTION CHAPTER 21 FILED WITH SECRETARY OF STATE APRIL 11, 2016 ADOPTED IN SENATE MARCH 31, 2016 ADOPTED IN ASSEMBLY APRIL 7, 2016 INTRODUCED BY Senator Hill (Principal coauthor: Assembly Member Mullin) (Coauthors: Senators Bates, Berryhill, Block, Galgiani, Mendoza, and Wolk) (Coauthors: Assembly Members Calderon, Chávez, Frazier, Gordon, Low, Maienschein, Waldron, and Wilk) MARCH 16, 2016 Relative to Biotechnology Day. LEGISLATIVE COUNSEL'S DIGEST SCR 120, Hill. Biotechnology Day. This measure would declare April 7, 2016, and every April 7 thereafter, as Biotechnology Day in California. WHEREAS, California is the global leader in the life sciences industry; and WHEREAS, This great state is home to the entire continuum of the life sciences industry, including world class universities, basic research centers, biotechnology startups, and anchor biopharmaceutical companies; and WHEREAS, There are currently 2,848 life sciences companies in California, with 212 more companies than in 2014, generating $130 billion in revenue; and WHEREAS, California life sciences companies directly employ 281,000 people all over the State of California, with concentrations in the San Francisco Bay area, San Diego, Orange County, and Los Angeles; and WHEREAS, The life sciences are an economic driver in California, a place where cutting-edge businesses thrive; and WHEREAS, California has a concentration of research in the life sciences industry; and WHEREAS, California companies have 1,235 potential new medicines in the pipeline and life science innovations have a tremendous impact on the world's health and well-being; and WHEREAS, New medicines and technologies emerging from California companies and research institutions are likely to have a remarkable impact on the health of the world's population and help those afflicted with serious diseases, such as cancer, cystic fibrosis, heart disease, multiple sclerosis, and rheumatoid arthritis; and WHEREAS, In the early 1970s, Herb Boyer at the University of California and geneticist Stanley Cohen at Stanford University pioneered a new scientific field called recombinant DNA technology; and WHEREAS, Venture capitalist, Bob Swanson, who was excited by recombinant DNA technology's potential to help people, and Herb Boyer together founded the first biotechnology company, Genentech, in South San Francisco; and WHEREAS, The founding of Genentech on April 7, 1976, marked the birth of the biotechnology industry and planted the industry's roots in California; and WHEREAS, Genentech, a member of the Roche Group, remains a leader in the biotechnology industry and continues to advance its mission of transforming the lives of people with serious diseases; and WHEREAS, The biotechnology industry inspires the next generation of scientists to help solve challenges like disease, energy, and food security; and WHEREAS, The biotechnology industry generates nearly $259 billion in economic activity in California, provides more than one million jobs, and is the source of billions of dollars in state and local tax revenue; and WHEREAS, The largest and most influential biotechnology convention in the world, the BIO International Convention, will take place in San Francisco, California, from June 6th to June 9th, 2016, with more than 15,000 anticipated attendees; and WHEREAS, San Francisco hosted this convention in 1995 and San Diego will host it in 2017, while the State of California has hosted this convention five other times; and WHEREAS, The BIO International Convention is where the global biotech community meets, connecting the people, companies, and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world; now, therefore, be it Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature hereby recognizes April 7, 2016, and every April 7th thereafter, as Biotechnology Day in California; and be it further Resolved, That the Senate urges Californians to recognize the value and importance of the life sciences industry; and be it further Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.